Your trusted source for investing success

Tag: patients

What is Medical Device Security?

What is Medical Device Security?

The bigger problem is when these attacks are against healthcare companies carrying millions of patients personal information; the attacks can lead to postponed surgeries, leaking information or even shutting down entire computer networks in hospitals.

Invictus’ Acreage Pharms’ Acquires 23 New Strains

Invictus’ Acreage Pharms’ Acquires 23 New Strains

INVICTUS MD STRATEGIES CORP.’s (“Invictus” or the “Company”) (TSXV:IMH) Acreage Pharms Ltd. (“Acreage Pharms”) is pleased to announce it has acquired 23 new cannabis strains. This marks an important step in Acreage Pharms’ march towards full-capacity cannabis production and sale this year.

Eyecarrot Announces Commercial Launch of Binovi in Spain

Eyecarrot Announces Commercial Launch of Binovi in Spain

Eyecarrot Innovations Corp (TSXV:EYC) is pleased to announce the full commercial release of BinoviTM into the Spanish market. The full launch will be announced at the 2018 Sociedad Internacional de Optometria del Desarrollo y Comportamiento (International Society of Developmental and Behavioural Optometry) Conference in March.

Wave Life Sciences and Takeda Form Global Strategic Collaboration

Wave Life Sciences (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced the formation of a global strategic collaboration with Takeda Pharmaceutical Company (TYO:4502) to discover, develop and commercialize nucleic acid therapies for disorders of the central nervous system (CNS).

As quoted in

Shire, Microsoft and EURORDIS form Global Commission

Shire (NASDAQ:SHPG), Microsoft (NASDAQ:MSFT) and EURORDIS-Rare Diseases Europe today announced a strategic alliance to address the diagnostic challenge for patients living with a rare disease. The long road to diagnosis is one of the most important issues affecting the health, longevity and well-being for rare disease patients and their families.

As

3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma

3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma

3D Signa­­­­­­tures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”) is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HLTM, 3DS’ test in development for Hodgkin’s lymphoma (HL), shows that the Company’s TeloViewTM platform is able to distinguish, with a high degree of statistical significance,

5 Artificial Intelligence Stocks

5 Artificial Intelligence Stocks

The AI sector is poised to grow by a CAGR of 52 percent between 2017 and 2025, making it a hot industry for investors to jump in on. Here’s a look at 5 AI-related stocks.

What Is In-Licensing?

What Is In-Licensing?

Licensing deals might be pharma’s preferred mode of business development these days—perhaps even more so than outright acquisitions.

Pernix Therapeutics Launches Generic Version of Treximet by Company’s Subsidiary, Macoven Pharmaceuticals

Pernix Therapeutics (NASDAQ:PTX), a specialty pharmaceutical company, announced the launch of an authorized generic version of Treximet® (sumatriptan/naproxen sodium) in the U.S. by the Company’s subsidiary, Macoven Pharmaceuticals, LLC.  Treximet is a prescription medicine that contains sumatriptan and naproxen sodium (a NSAID) and is indicated for the treatment of acute

AIT Therapeutics Announces $9.82 Million Private Placement

AIT Therapeutics (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung infections and pulmonary hypertension, today announced that it has completed a private placement with a select group of investors, which, assuming the exercise of the Tranche A portion

Sientra Launches New miraDry fresh Protocol for the miraDry System

miraDry a subsidiary of Sientra (NASDAQ:SIEN) a medical aesthetics company, today announced the launch of a new, improved treatment protocol for the miraDry system. Launching at the American Academy of Dermatology Annual Meeting  in San Diego, CA, February 16-18, 2018, the new miraDry freshprotocol reduces overall procedure time by up to

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Tandem Diabetes Care Applies for Medical Device License in Canada

URL: https://investingnews.com/daily/life-science-investing/medical-device-investing/tandem-medical-device-license-health-canada/